tiprankstipranks
Advertisement
Advertisement
Replimune upgraded to Outperform from Neutral at Wedbush
PremiumThe FlyReplimune upgraded to Outperform from Neutral at Wedbush
6d ago
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
Premium
The Fly
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
7d ago
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
Premium
The Fly
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
9d ago
Roblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
PremiumThe FlyRoblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
13d ago
Morning Movers: Amazon jumps after quarterly results while Apple slips
Premium
The Fly
Morning Movers: Amazon jumps after quarterly results while Apple slips
13d ago
Piper upgrades Replimune to Overweight on better odds of RP1 approval
Premium
The Fly
Piper upgrades Replimune to Overweight on better odds of RP1 approval
13d ago
Replimune upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe FlyReplimune upgraded to Overweight from Neutral at Cantor Fitzgerald
13d ago
Replimune confirms FDA AdCom voted in favor of experimental melanoma treatment
Premium
The Fly
Replimune confirms FDA AdCom voted in favor of experimental melanoma treatment
14d ago
FDA panel votes 10-3 in favor of Replimune’s experimental melanoma treatment
Premium
The Fly
FDA panel votes 10-3 in favor of Replimune’s experimental melanoma treatment
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100